首页> 外文期刊>Journal of Hepatology: The Journal of the European Association for the Study of the Liver >Protein expression of CD44 (standard and variant isoforms) in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, p53 expression, and patient survival.
【24h】

Protein expression of CD44 (standard and variant isoforms) in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, p53 expression, and patient survival.

机译:肝细胞癌中CD44(标准和变异同工型)的蛋白表达:与肿瘤等级,临床病理参数,p53表达和患者生存率的关系。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND/AIMS: Members of the CD44 family are transmembrane glycoproteins which act mainly as receptors for hyaluronan. We have examined the expression of CD44s and several CD44v and the relationship between these and hepatocellular carcinoma (HCC) grade, clinicopathological parameters, p53 expression, and patient survival in HCC. METHODS: Formalin-fixed, paraffin-embedded tissue sections from 107 surgically resected HCC were examined immunohistochemically using a semi-quantitative scoring system to detect the expression of different forms of CD44. RESULTS: The number of CD44s-positive cases was 36 (34%), CD44v5 52 (49%), CD44v6 29 (27%), CD44v7-8 41 (38%), and CD44v10 26 (24%). Expression of these molecules correlated with high histological grade, being the highest in poorly-differentiated HCC. High CD44v6 expression significantly correlated with the presence of vascular invasion and p53 overexpression. Kaplan-Meier examination of patient survival revealed that HCC patients with positivity of each of these five molecules had a reduced survival rate, and that HCC patients positive for all the five CD44 molecules had worse survival than HCC patients positive for four or less of these CD44 molecules. In multivariate survival analysis, CD44s positivity was an independent factor. However, positivity for one or more CD44 isoforms was the most useful independent factor for overall survival. CONCLUSION: These results suggest that up-regulation of CD44 isoforms is associated with poorly-differentiated HCC and shortened survival.
机译:背景/目的:CD44家族的成员是跨膜糖蛋白,主要作为透明质酸的受体。我们已经检查了CD44s和几种CD44v的表达,以及它们与肝细胞癌(HCC)等级,临床病理参数,p53表达和HCC患者生存率之间的关系。方法:采用半定量评分系统免疫组织化学方法检测107例手术切除的肝癌中福尔马林固定,石蜡包埋的组织切片,以检测不同形式的CD44的表达。结果:CD44s阳性病例数为36(34%),CD44v5 52(49%),CD44v6 29(27%),CD44v7-8 41(38%)和CD44v10 26(24%)。这些分子的表达与高组织学等级相关,在低分化肝癌中最高。高CD44v6表达与血管入侵和p53过表达的存在显着相关。 Kaplan-Meier对患者生存率的检查显示,这五个分子中的每一个阳性的HCC患者的生存率均降低,并且所有五个CD44分子均为阳性的HCC患者的生存率低于四个或以下CD44阳性的HCC患者分子。在多因素生存分析中,CD44s阳性是一个独立因素。然而,一种或多种CD44亚型的阳性是整体生存最有用的独立因素。结论:这些结果表明,CD44亚型的上调与低分化的肝癌和缩短的生存期有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号